Document is current
Any future updates will be listed below
-
Authors
Bogsrud, Trond Velde https://orcid.org/0000-0002-9451-4648
Durski, Jolanta M.
Engelsen, Ola
Zhang, Jun
Thorpe, Matt P.
Sartor, Oliver
- License Information
-
More Information
Article History
Received: 28 May 2025
Accepted: 24 June 2025
First Online: 30 June 2025
Declarations
:
: N/A.
: Oliver Sartor reports consulting fees from ARTBIO, AstraZeneca, Bayer, Clarity Pharmaceuticals, Fusion, Isotopen Technologien Muenchen, Janssen, Merck, Myovant, Myriad, Noria Therapeutics, NorthStar, Novartis, Pfizer, POINT Biopharma, Sanofi, Telix, and advisory board for AstraZeneca, Merck, and Pfizer. Oliver Sartor has institutional grants or contracts from Amgen, AstraZeneca, Bayer, Endocyte, Janssen, Lantheus, Merck, Novartis, and travel and accommodation expenses from Lantheus, NorthStar, and Novartis. Oliver Sartor has stock or stock options in ARTBIO, Clarity Pharmaceuticals, Convergent, Fusion, Lilly, Pfizer, Ratio, and Telix. Other authors have nothing to disclose. We acknowledge that the information presented in our letter conflicts with current standards of care.
